These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8241371)

  • 21. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A group sequential procedure for all-pairwise comparisons of k treatments based on the range statistic.
    Liu W
    Biometrics; 1995 Sep; 51(3):946-55. PubMed ID: 7548710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interim treatment selection using the normal approximation approach in clinical trials.
    Shun Z; Lan KK; Soo Y
    Stat Med; 2008 Feb; 27(4):597-618. PubMed ID: 17619239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive treatment for the fit elderly with non-small-cell lung cancer? Yes!
    Sequist LV; Lynch TJ
    J Clin Oncol; 2003 Sep; 21(17):3186-8. PubMed ID: 12874267
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
    Kubota K
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints.
    Xu H; Nuamah I; Liu J; Lim P; Sampson A
    Pharm Stat; 2009; 8(4):301-16. PubMed ID: 19065544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria.
    Komaki R; Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Weisenburger TH; Kaiser LR; Leibel SA; Choi NC
    Radiology; 2000 Jun; 215 Suppl():1319-30. PubMed ID: 11037549
    [No Abstract]   [Full Text] [Related]  

  • 30. Three p-value consistent procedures for multiple comparisons with a control in direction-mixed families.
    Kwong KS; Cheung SH; Holland B; Wang Y
    Stat Med; 2007 Oct; 26(23):4253-72. PubMed ID: 17342699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extension of one-sided test to multiple treatment trials.
    Chen TT; Simon RM
    Control Clin Trials; 1994 Apr; 15(2):124-34. PubMed ID: 8205803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approximate simultaneous confidence intervals for multiple contrasts of binomial proportions.
    Schaarschmidt F; Sill M; Hothorn LA
    Biom J; 2008 Oct; 50(5):782-92. PubMed ID: 18932137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer.
    Kim DW; Shyr Y; Chen H; Akerley W; Johnson DH; Choy H
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1029-36. PubMed ID: 15913910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surgery and chemoradiation in stage IIIA non-small cell lung cancer].
    Hennequin C; Girard N; Mornex F
    Cancer Radiother; 2006 Nov; 10(6-7):477-83. PubMed ID: 17046307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A stepdown procedure with feedback for identifying inferiority among three treatments.
    Lin CJ; Hayter AJ
    Biom J; 2008 Oct; 50(5):884-96. PubMed ID: 18932129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive Dunnett tests for treatment selection.
    Koenig F; Brannath W; Bretz F; Posch M
    Stat Med; 2008 May; 27(10):1612-25. PubMed ID: 17876763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of non-small cell lung cancers (NSCLC)].
    Jacoulet P; Depierre A
    Rev Prat; 1993 Apr; 43(7):845-51. PubMed ID: 8394026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A note on P-values under group sequential testing and nonproportional hazards.
    Gillen DL; Emerson SS
    Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection designs for pilot studies based on survival.
    Liu PY; Dahlberg S; Crowley J
    Biometrics; 1993 Jun; 49(2):391-8. PubMed ID: 8369375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.